Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Neurochem Res ; 34(1): 79-86, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18408997

ABSTRACT

The myelin-associated glycoprotein (MAG) is selectively localized in periaxonal Schwann cell and oligodendroglial membranes of myelin sheaths suggesting that it functions in glia-axon interactions in the PNS and CNS, and this is supported by much experimental evidence. In addition, MAG is now well known as one of several white matter inhibitors of neurite outgrowth in vitro and axonal regeneration in vivo, and this latter area of research has provided a substantial amount of information about neuronal receptors or receptor complexes for MAG. This article makes the hypothesis that the capacity of MAG to inhibit outgrowth of immature developing or regenerating neurites is an aberration of its normal physiological function to promote the maturation, maintenance, and survival of myelinated axons. The overview summarizes the literature on the function of MAG in PNS and CNS myelin sheaths and its role as an inhibitor of neurite outgrowth to put this hypothesis into perspective. Additional research is needed to determine if receptors and signaling systems similar to those responsible for MAG inhibition of neurite outgrowth also promote the maturation, maintenance, and survival of myelinated axons as hypothesized here, or if substantially different MAG-mediated signaling mechanisms are operative at the glia-axon junction.


Subject(s)
Axons/physiology , Myelin Sheath/physiology , Myelin-Associated Glycoprotein/physiology , Neurites/physiology , Animals , GPI-Linked Proteins , Models, Neurological , Myelin Proteins , Neurites/drug effects , Nogo Receptor 1 , Receptors, Cell Surface/physiology , Receptors, Peptide/physiology
2.
J Neurochem ; 100(6): 1431-48, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17241126

ABSTRACT

The myelin-associated glycoprotein (MAG) is a type I transmembrane glycoprotein localized in periaxonal Schwann cell and oligodendroglial membranes of myelin sheaths where it functions in glia-axon interactions. It contains five immunoglobulin (Ig)-like domains and is in the sialic acid-binding subgroup of the Ig superfamily. It appears to function both as a ligand for an axonal receptor that is needed for the maintenance of myelinated axons and as a receptor for an axonal signal that promotes the differentiation, maintenance and survival of oligodendrocytes. Its function in the maintenance of myelinated axons may be related to its role as one of the white matter inhibitors of neurite outgrowth acting through a receptor complex involving the Nogo receptor and/or gangliosides containing 2,3-linked sialic acid. MAG is expressed as two developmentally regulated isoforms with different cytoplasmic domains that may activate different signal transduction pathways in myelin-forming cells. MAG contains a carbohydrate epitope shared with other glycoconjugates that is a target antigen in autoimmune peripheral neuropathy associated with IgM gammopathy and has been implicated in a dying back oligodendrogliopathy in multiple sclerosis.


Subject(s)
Myelin-Associated Glycoprotein/physiology , Schwann Cells/metabolism , Animals , Axons/metabolism , Humans , Models, Biological , Schwann Cells/cytology
4.
Ann Neurol ; 54(6): 769-80, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14681886

ABSTRACT

Two brothers with a leukodystrophy, progressive spastic diplegia, and peripheral neuropathy were found to have proteinaceous aggregates in the peripheral nerve myelin sheath. The patients' mother had only subclinical peripheral neuropathy, but the maternal grandmother had adult-onset leukodystrophy. Sequencing of the proteolipid protein (PLP) gene showed a point mutation IVS4 + 1 G-->A within the donor splice site of intron 4. We identified one transcript with a deletion of exon 4 (Deltaex4, 169bp) encoding for PLP and DM20 proteins and lacking two transmembrane domains, and a second transcript with exon 4 + 10bp encoding three transmembrane domains. Immunohistochemistry showed abnormal aggregation in the myelin sheath of MBP and P0. Myelin-associated glycoprotein was present in the Schmidt-Lanterman clefts but significantly reduced in the periaxonal region. Using immunogold electron microscopy, we demonstrated the presence of mutated PLP/DM20 and the absence of the intact protein in the patient peripheral myelin sheath. We conclude that insertion of mutant PLP/DM20 with resulting aberrant distribution of other myelin proteins in peripheral nerve may constitute an important mechanism of dysmyelination in disorders associated with PLP mutations.


Subject(s)
Demyelinating Diseases/genetics , Membrane Proteins , Mutagenesis, Insertional , Myelin Proteins/metabolism , Myelin Proteolipid Protein/genetics , Point Mutation , Adult , Amino Acid Sequence , Child , Demyelinating Diseases/pathology , Female , Humans , Male , Middle Aged , Molecular Sequence Data , Myelin Sheath/genetics , Myelin Sheath/pathology , Pedigree , Sural Nerve/pathology
5.
J Neurosci Res ; 69(4): 497-508, 2002 Aug 15.
Article in English | MEDLINE | ID: mdl-12210843

ABSTRACT

Primary and immortalized cultured Schwann cells are commonly utilized in analyses of myelin gene promoters, but few lines are well-characterized in terms of their endogenous expression of myelin genes. This is particularly significant in that cultured Schwann cells typically do not express myelin genes at levels comparable to those observed in vivo. In this study, the steady-state levels of mRNA and protein for five Schwann cell markers (PMP22, P0, MBP, MAG, and LNGF-R) were assessed in primary Schwann cells and six representative Schwann cell lines (RT4-D6P2T, JS-1, RSC96, R3, S16, and S16Y). RT4-D6P2T and S16 cells were the most similar to myelinating Schwann cells based on their comparatively high expression of PMP22 and P0 mRNA. Both RT4-D6P2T and S16 also expressed P0 protein. In addition, the previously reported P1-A positive regulatory region from the myelination-specific PMP22 promoter demonstrated significant activity in both these cell lines. However, nuclear proteins that interacted with P1-A were different in extracts prepared from RT4-D6P2T and S16 cells. Primary Schwann cells expressed myelin proteins at levels that were equal or less than those observed with the RT4-D6P2T and S16 lines, indicating that primary Schwann cells are not necessarily better than immortalized Schwann cells as model systems for the study of myelin gene regulation. The data presented here demonstrate that cultured Schwann cells used to study myelin gene promoters have to be carefully selected on the basis of the endogenous level of expression of the myelin gene under study.


Subject(s)
Cell Culture Techniques/methods , Cell Line/metabolism , Gene Expression Regulation/physiology , Models, Biological , Myelin Proteins/genetics , Schwann Cells/metabolism , Animals , Cell Line/cytology , Cell Line, Transformed/cytology , Cell Line, Transformed/metabolism , DNA/analysis , DNA/genetics , Electrophoretic Mobility Shift Assay , Genes, Regulator/genetics , Myelin Basic Protein/genetics , Myelin Basic Protein/metabolism , Myelin P0 Protein/genetics , Myelin P0 Protein/metabolism , Myelin Proteins/biosynthesis , Myelin Proteins/metabolism , Myelin-Associated Glycoprotein/genetics , Myelin-Associated Glycoprotein/metabolism , Promoter Regions, Genetic/genetics , RNA, Messenger/metabolism , Rats , Schwann Cells/cytology
6.
J Neurochem ; 81(6): 1263-72, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12068074

ABSTRACT

Decreased phosphorylation of neurofilaments in mice lacking myelin-associated glycoprotein (MAG) was shown to be associated with decreased activities of extracellular-signal regulated kinases (ERK1/2) and cyclin-dependent kinase-5 (cdk5). These in vivo changes could be caused directly by the absence of a MAG-mediated signaling pathway or secondary to a general disruption of the Schwann cell-axon junction that prevents signaling by other molecules. Therefore, in vitro experimental paradigms of MAG interaction with neurons were used to determine if MAG directly influences expression and phosphorylation of cytoskeletal proteins and their associated kinases. COS-7 cells stably transfected with MAG or with empty vector were co-cultured with primary dorsal root ganglion (DRG) neurons. Total amounts of the middle molecular weight neurofilament subunit (NF-M), microtubule-associated protein 1B (MAP1B), MAP2, and tau were up-regulated significantly in DRG neurons in the presence of MAG. There was also increased expression of phosphorylated high molecular weight neurofilament subunit (NF-H), NF-M, and MAP1B. Additionally, in similar in vitro paradigms, total and phosphorylated NF-M were increased significantly in PC12 neurons co-cultured with MAG-expressing COS cells or treated with a soluble MAG Fc-chimera. The increased expression of phosphorylated cytoskeletal proteins in the presence of MAG in vitro was associated with increased activities of ERK 1/2 and cdk5. We propose that interaction of MAG with an axonal receptor(s) induces a signal transduction cascade that regulates expression of cytoskeletal proteins and their phosphorylation by these proline-directed protein kinases.


Subject(s)
Cytoskeleton/metabolism , Myelin-Associated Glycoprotein/physiology , Neurons/metabolism , Phosphotransferases/metabolism , Animals , COS Cells , Coculture Techniques , Mice , Mice, Inbred C57BL , Mice, Knockout/genetics , Myelin-Associated Glycoprotein/genetics , Neurofilament Proteins/metabolism , PC12 Cells , Phosphorylation , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...